Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (+)-jq1 Compound
2. Bet Inhibitor Jq1
3. Jq1 Compound
1. 1268524-70-4
2. (+)-jq1
3. (+)-jq-1
4. Jq1 Compound
5. Jq1
6. Jq-1
7. (s)-tert-butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate
8. (s)-jq1
9. Bromodomain Inhibitor, (+)-jq1
10. 1mrh0imx0w
11. C23h25cln4o2s
12. Chembl1957266
13. 6h-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine-6-acetic Acid, 4-(4-chlorophenyl)-2,3,9-trimethyl-, 1,1-dimethylethyl Ester, (6s)-
14. Tert-butyl (s)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate
15. Tert-butyl 2-((6s)-4-(4-chlorophenyl)-2,3,9-trimethyl-6h-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-6-yl)acetate
16. (s)-(+)-tert-butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate
17. 3mxf
18. 6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic Acid, 4-(4-chlorophenyl)-2,3,9-trimethyl-, 1,1-dimethylethyl Ester, (6s)-
19. Unii-1mrh0imx0w
20. 4flp
21. 4qzs
22. (6s)-4-(4-chlorophenyl)-2,3,9-trimethyl-6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic Acid 1,1-dimethylethyl Ester
23. Tert-butyl 2-((6s)-4-(4-chlorophenyl)-2,3,9-trimethyl-6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate
24. Mls006011158
25. Schembl881227
26. Gtpl7511
27. Chebi:95080
28. Dtxsid20155309
29. Ex-a457
30. Chebi:137113
31. Bdbm50365262
32. Nsc760183
33. Nsc764043
34. S7110
35. Zinc57318556
36. Akos016344680
37. (+)jq-1
38. Ccg-269306
39. Cs-0581
40. Jq1 (+)
41. Jq1-(+)
42. Nsc-760183
43. Nsc-764043
44. Ncgc00250412-01
45. Ncgc00250412-15
46. Ncgc00250412-21
47. (s)-tert-butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diaz
48. Ac-32617
49. As-16352
50. Bp-21590
51. Hy-13030
52. Smr004702930
53. Bb 0262647
54. (+)-jq1, >=98% (hplc)
55. A854208
56. Q3156953
57. (6s)-4-(4-chlorophenyl)-2,3,9-trimethyl-6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]di Azepine-6-acetic Acid 1,1-dimethylethyl Ester
58. Tert-butyl (s)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate;(s)-(+)-tert-butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate
59. Tert-butyl [(6s)-4-(4-chlorophenyl)-2,3,9-trimethyl-6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]acetate
60. Tert-butyl 2-[(9s)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-9-yl]acetate
61. Tert-butyl[(s)-4-(4-chlorophenyl)-2,3,9-trimethyl-6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]acetate
| Molecular Weight | 457.0 g/mol |
|---|---|
| Molecular Formula | C23H25ClN4O2S |
| XLogP3 | 4.9 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 5 |
| Exact Mass | 456.1386749 g/mol |
| Monoisotopic Mass | 456.1386749 g/mol |
| Topological Polar Surface Area | 97.6 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 706 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A JQ 1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of JQ 1, including repackagers and relabelers. The FDA regulates JQ 1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. JQ 1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A JQ 1 supplier is an individual or a company that provides JQ 1 active pharmaceutical ingredient (API) or JQ 1 finished formulations upon request. The JQ 1 suppliers may include JQ 1 API manufacturers, exporters, distributors and traders.
JQ 1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of JQ 1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right JQ 1 GMP manufacturer or JQ 1 GMP API supplier for your needs.
A JQ 1 CoA (Certificate of Analysis) is a formal document that attests to JQ 1's compliance with JQ 1 specifications and serves as a tool for batch-level quality control.
JQ 1 CoA mostly includes findings from lab analyses of a specific batch. For each JQ 1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
JQ 1 may be tested according to a variety of international standards, such as European Pharmacopoeia (JQ 1 EP), JQ 1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (JQ 1 USP).
LOOKING FOR A SUPPLIER?
